
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
Key Takeaways
There's a strong parallel between for passive income and planting an apple tree. Both require some work up front. But if all goes well, you can reap the fruits of those...
Article Overview
Quick insights and key information
4 min read
Estimated completion
real estate
Article classification
July 5, 2025
05:41 AM
The Motley Fool
Original publisher
There's a strong parallel between for passive income and planting an apple tree
Both require some work up front
But if all goes well, you can reap the fruits of those labors (literally, in the case of the apple tree) for years afterward
Of course, there are some potential pitfalls
An apple tree could become diseased and stop bearing fruit
Similarly, the companies you invest in could struggle and stop distributing income
The good news for investors is that selecting the right dividend stocks can minimize the risk of that happening
Want decades of passive income
Here are three stocks to buy now and hold forever
Image source: Getty Images
AbbVie If you're looking for the companies with the best dividend track records, you'll want to check out the elite group of stocks known as the Dividend Kings
The list includes over 50 stocks
I think AbbVie (ABBV -0. 93%) ranks as one of the best
Many of the Dividend Kings don't offer kingly yields
At its current price, the drugmaker's forward dividend yield stands at 3
Moreover, AbbVie has increased its payouts annually for 53 consecutive years
It has more than quadrupled its dividend since its spinoff from Abbott Laboratories in 2013
You'll get more than just a dividend with AbbVie, though
The company should have solid growth spects thanks to rising stars such as Rinvoq, Skyrizi, Ubrelvy, and Qulipta
AbbVie's pipeline looks mising as well, with around 90 grams in clinical development, roughly 50 of which are in mid- or late-stage testing
Perhaps the most impressive thing AbbVie, other than its dividend, is the company's resilience
Not long ago, it faced the loss of patent exclusivity for its top-selling duct, the autoimmune disease drug Humira
Today, the company has two successors treatments to Humira that together are on track to be even bigger winners
Enbridge Want even more passive income
Consider in Enbridge (ENB -0
At its current price, this mid energy leader offers a forward dividend yield that's a hair over 6%
And while Enbridge isn't a Dividend King AbbVie, it has increased its payouts annually for an impressive 30 consecutive years
AbbVie, Enbridge has a highly resilient
Around 80% of its earnings before interest, taxes, depreciation, and amortization (EBITDA) are tected against inflation
Less than 1% of its EBITDA is tied to volatile commodity prices
Roughly 98% of its EBITDA is either regulated or contracted via take-or-pay agreements (where buyers commit to either purchase ducts or pay a penalty if they don't)
Enbridge is one of the biggest mid energy companies
Its pipelines transport around 30% of the crude oil duced in North America and 40% of total U
It also transports close to 20% of all natural gas used in the U
In addition, thanks to some strategic acquisitions in 2023, Enbridge now ranks as the largest natural gas utility in North America by volume
This helps lower the company's risk level even more
I think Enbridge's utility also makes the passive income the company generates more dependable
Realty Income Realty Income (O -0. 09%) stacks up pretty well with Enbridge when it comes to dividends
The real estate investment trust (REIT) pays a forward dividend yield of 5. 6% at the current price
Realty Income has also boosted its dividend annually for 30 consecutive years
Another attribute that will appeal to many investors is that Realty Income distributes its dividends monthly rather than quarterly
It even trademarked the name "The Monthly Dividend Company. " Realty Income has a strong tenant base, leasing perties to 1,598 different clients across 91 industries
Its triple-net leases generate nearly 100% gross margins since its tenants are responsible for covering major perty expenses such as insurance, maintenance, perty taxes, and utilities
These leases are also usually long, which vides the REIT with consistent, recurring revenue
I also Realty Income's long-term growth spects
The company targets a total addressable market of around $14 trillion
More than 60% of this market is in Europe, where Realty Income faces only two major rivals
Keith Speights has positions in AbbVie, Enbridge, and Realty Income
The Motley Fool has positions in and recommends AbbVie, Abbott Laboratories, Enbridge, and Realty Income
The Motley Fool has a disclosure policy.
Related Articles
More insights from FinancialBooklet